Circe Bioscience, spun out of the Wyss Institute at Harvard in 2021, is a biotechnology startup specializing in carbon-negative manufacturing. The company has developed a proprietary gas fermentation platform that can produce a wide range of organic molecules, such as tailored fats and oils, using genetically engineered microbes, CO2, water, and electricity.
The company's patented process mimics the biochemical pathway used by plants to fix CO2, enabling its microbes to consume CO2 and produce different types of fats. Moreover, this technology allows for the precise engineering of microbial metabolisms, granting genetic control over the final fat or oil product, enabling the company to manufacture a wide range of fats and oils for various food applications in a scalable manner.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.